Can Wegovy cause mood changes — and how worried should you be?

Does Wegovy directly cause low mood or depression?

The honest answer is: regulators consider it possible but not established as a direct pharmacological effect. The Summary of Product Characteristics for Wegovy lists depression, suicidal ideation and suicidal behaviour under adverse reactions, classified as uncommon, meaning they occurred in fewer than one in a hundred trial participants but more than one in a thousand. That distinction matters. Uncommon is not rare, and it is not zero.

What makes the picture complicated is that obesity itself is strongly associated with depression, and so is significant rapid weight loss. When someone starts a medicine like semaglutide, several things change at once: calorie intake drops, hunger signals are suppressed, and social and psychological dynamics around food shift noticeably. Unpicking which thread (the medicine, the diet change, or pre-existing vulnerability) is genuinely difficult. The relationship between semaglutide and mood is an active area of pharmacovigilance research, and the NHS encourages patients to report anything unusual through the Yellow Card scheme at yellowcard.mhra.gov.uk.

One more factor: GLP-1 receptors exist in the brain, not just the gut. Early research suggests semaglutide may influence reward and motivation pathways. Whether that translates to clinically meaningful mood change in most people remains under study. For now, the guidance is watchful awareness rather than alarm.

What symptoms should prompt you to act quickly?

Most people do not experience significant mood disruption on Wegovy. But there are specific symptoms that warrant prompt contact with a healthcare professional rather than waiting to see whether things settle. These include persistent low mood that does not lift after a few days, a marked loss of interest in things that previously gave you pleasure, heightened anxiety, and (most urgently) any thoughts of harming yourself or ending your life.

If those thoughts are present, do not wait for a routine appointment. Call 111, speak to your GP the same day, or go to your nearest urgent care centre. The Samaritans are available around the clock on 116 123. These are not overreactions; they are the steps the MHRA and prescribers recommend taking seriously.

It is also worth knowing that mood can dip for practical reasons early in treatment. Nausea, fatigue and disrupted eating patterns (all common in the first few weeks) are tiring, and being tired makes everything feel harder. If the low mood tracks closely with those physical symptoms and improves as they settle, that context is useful to share with your prescriber. Either way, whether Wegovy is changing your mood or something else is at work, your clinical team needs to know.

Should a history of depression or anxiety stop you from using Wegovy?

Not automatically. A previous diagnosis of depression or anxiety is not listed as an absolute contraindication in Wegovy's UK prescribing information. What it does mean is that your prescriber will factor it into their assessment. At nume, sorry: at a service like ours, a GPhC-registered prescriber reads your full consultation, not a checkbox algorithm. Mental-health history is part of that picture.

For many people with a history of depression, weight loss itself brings genuine improvements in mood and self-esteem over time. The clinical calculus involves weighing those potential long-term gains against a small additional risk of mood disruption, particularly in the early weeks of treatment. That is a conversation, not a blanket rule.

If you are currently taking antidepressants, there is an additional practical consideration: semaglutide slows gastric emptying, which can affect how oral medicines are absorbed. Discuss timing and monitoring with whoever manages your mental-health treatment. The evidence on semaglutide's effect on mood continues to develop, and your prescriber can advise based on your specific circumstances. Our clinical team reviews each patient's history personally before approving treatment.

How is mood monitored during Wegovy treatment?

Good monitoring is built into responsible prescribing. Before treatment starts, your prescriber should establish a baseline picture of your mental health. During treatment, any new or worsening symptoms (even mild ones) should be reported. If something has changed noticeably since your last clinical contact, the right move is to get in touch rather than log it for the next routine check-in.

At nume, clinical re-review happens before every repeat order. That is not a formality; it is the moment to flag mood changes, new symptoms, or anything else that has shifted. The full picture of how Wegovy affects mood in practice is one of the things our prescribers discuss with patients at those intervals. There is no subscription mechanic that auto-dispatches the next pen without someone looking at how you are getting on.

If you are weighing up the overall cost and benefit of starting treatment, the cost context for Wegovy in the UK is worth reading alongside this safety information, understanding what responsible private prescribing includes helps you compare services on the right criteria. And if you have questions that this page has not answered, our FAQs and support team are available seven days a week.

If you are ready to discuss whether Wegovy is appropriate for you, check your eligibility with our prescribers, consultations are free, and the clinical review happens the same day.